35 results
Thumbnail

D1.200 - Allergenicity of profilin isoallergens from Korean melon

Thumbnail

D1.201 - Safety and Effectiveness of Subcutaneous Immunotherapy with Non-Homologous Aeroallergen Mixtures: A Real-World Study

Thumbnail

D1.202 - Comparison of 2 different medication scores for the calculation of the Combined Symptom and Medication Score – EAACI versus paediatric medication in Germany

Thumbnail

D1.203 - Prospective study to investigate the symptom profile and medication consumption of patients with seasonal allergic rhinitis/rhinoconjunctivitis who are interested in allergen-specific immunotherapy

Thumbnail

D1.206 - Local allergic rhinitis to birch pollen: a case of transient IgE+ plasmablast detection and successful sublingual immunotherapy

Thumbnail

D1.207 - Molecular Patterns and Age-Related Evolution of Pollen Sensitization in Children

Thumbnail

D1.213 - Staphylococcus aureus enterotoxins in allergic rhinitis: impact on disease severity and molecular sensitization profile

Thumbnail

D1.215 - Safety of subcutaneous immunotherapy with purified native protein Alt a 1, a major allergen of Alternaria alternata: 7-year real-world data

Thumbnail

D1.216 - AIT prescription drivers: a factor analysis of data from the CHOICE survey

Thumbnail

D1.217 - Reduction in healthcare resource utilization in pediatric patients treated with 300 IR liquid SLIT: a real‑world subanalysis from Spain and Italy

Thumbnail

D1.205 - Immunological characterization of recombinant Sal k 1 produced in Nicotiana benthamiana and potential immunomodulatory role of HSP90 in Salsola kali allergy

Thumbnail

D1.208 - Monocentric retrospective study of asthma prevalence among patients allergic to birch and grass pollens at Strasbourg University Hospital

Thumbnail

D1.214 - Analysis of the time to achieve a maintenance dose of tree pollen allergen in specific immunotherapy of allergic rhinitis

Thumbnail

D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)

Thumbnail

D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety

Thumbnail

D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A

Thumbnail

D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody

Thumbnail

D1.446 - Lebrikizumab in patients with urticarial vasculitis - a case series

Thumbnail

D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria

Thumbnail

D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis